Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Joint Bone Spine|January 25, 2017
Incidence of paradoxical reactions in patients treated with tocilizumab for rheumatoid arthritis: Data from the French registry REGATEWilliam Terreaux, Claire Masson, Jean-Paul Eschard, et al.
Rheumatology (Oxford, England)|December 19, 2022
Efficacy of subcutaneous vs intravenous infliximab in rheumatoid arthritis: a post-hoc analysis of a randomized phase III trialArnaud Constantin, Roberto Caporali, Christopher J Edwards, et al.
Joint Bone Spine|May 29, 2025
Early peripheral psoriatic arthritis: Baseline features of the first 186 patients in the French Nationwide APACHE CohortPascal Claudepierre, Cecile Gaujoux-Viala, Arnaud Constantin, et al.
Iscience|April 23, 2021
Evidence for tmTNF reverse signaling <i>in vivo</i>: Implications for an arginase-1-mediated therapeutic effect of TNF inhibitors during inflammationKaty Diallo, Numa Simons, Souraya Sayegh, et al.
Annals of the Rheumatic Diseases|June 18, 2014
SPP1 rs9138 variant contributes to the severity of radiological damage in anti-citrullinated protein autoantibody-negative rheumatoid arthritisPierre-Antoine Juge, Hanna W van Steenbergen, Arnaud Constantin, et al.
International Immunopharmacology|June 5, 2023
Infectious risk when prescribing rituximab in patients with hypogammaglobulinemia acquired in the setting of autoimmune diseasesXavier Boumaza, Margaux Lafaurie, Emmanuel Treiner, et al.
Rheumatology (Oxford, England)|September 29, 2017
Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATEJacques Morel, Arnaud Constantin, Gabriel Baron, et al.
BMJ (Clinical Research Ed.)|January 26, 2019
Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort studyJacques-Eric Gottenberg, Jacques Morel, Elodie Perrodeau, et al.
Clinical and Experimental Rheumatology|July 27, 2022
Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohortDewi Guellec, Guillermo Carvajal-Alegria, Claire Daïen, et al.
Rheumatology and Therapy|December 5, 2020
Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2)Ana-Maria Orbai, Jordi Gratacós, Anthony Turkiewicz, et al.
Pageof 11